- Home
- TOPP vs GDTC Comparison
TOPP vs GDTC Comparison
Compare TOPP & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- GDTC
- Stock Information
- Founded
- TOPP 2014
- GDTC 2018
- Country
- TOPP United States
- GDTC Singapore
- Employees
- TOPP N/A
- GDTC N/A
- Industry
- TOPP
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- TOPP
- GDTC Health Care
- Exchange
- TOPP NYSE
- GDTC Nasdaq
- Market Cap
- TOPP 26.6M
- GDTC 21.5M
- IPO Year
- TOPP 2025
- GDTC 2023
- Fundamental
- Price
- TOPP $2.19
- GDTC $1.86
- Analyst Decision
- TOPP
- GDTC Buy
- Analyst Count
- TOPP 0
- GDTC 1
- Target Price
- TOPP N/A
- GDTC $5.00
- AVG Volume (30 Days)
- TOPP 12.7K
- GDTC 18.1K
- Earning Date
- TOPP 08-11-2025
- GDTC 01-01-0001
- Dividend Yield
- TOPP N/A
- GDTC N/A
- EPS Growth
- TOPP N/A
- GDTC N/A
- EPS
- TOPP N/A
- GDTC N/A
- Revenue
- TOPP $16,117,227.00
- GDTC $368,838.00
- Revenue This Year
- TOPP N/A
- GDTC $5.37
- Revenue Next Year
- TOPP N/A
- GDTC N/A
- P/E Ratio
- TOPP N/A
- GDTC N/A
- Revenue Growth
- TOPP 0.44
- GDTC N/A
- 52 Week Low
- TOPP $0.97
- GDTC $1.20
- 52 Week High
- TOPP $4.50
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- GDTC 35.89
- Support Level
- TOPP N/A
- GDTC $1.85
- Resistance Level
- TOPP N/A
- GDTC $1.95
- Average True Range (ATR)
- TOPP 0.00
- GDTC 0.10
- MACD
- TOPP 0.00
- GDTC -0.02
- Stochastic Oscillator
- TOPP 0.00
- GDTC 23.53
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.